268 related articles for article (PubMed ID: 34129913)
1. The HECT family of E3 ubiquitin ligases and PTEN.
Song MS; Pandolfi PP
Semin Cancer Biol; 2022 Oct; 85():43-51. PubMed ID: 34129913
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer.
Sun A; Tian X; Chen Y; Yang W; Lin Q
Pathol Oncol Res; 2023; 29():1610931. PubMed ID: 36825281
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.
Shao C; Li Z; Ahmad N; Liu X
Cell Cycle; 2017 May; 16(10):957-967. PubMed ID: 28437168
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the catalytic regulation of NEDD4-1 and WWP2 ubiquitin ligases.
Jiang H; Thomas SN; Chen Z; Chiang CY; Cole PA
J Biol Chem; 2019 Nov; 294(46):17421-17436. PubMed ID: 31578285
[TBL] [Abstract][Full Text] [Related]
5. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
[TBL] [Abstract][Full Text] [Related]
6. HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.
Wang Y; Argiles-Castillo D; Kane EI; Zhou A; Spratt DE
J Cell Sci; 2020 Apr; 133(7):. PubMed ID: 32265230
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitination/de-ubiquitination: A promising therapeutic target for PTEN reactivation in cancer.
Wang K; Liu J; Li YL; Li JP; Zhang R
Biochim Biophys Acta Rev Cancer; 2022 May; 1877(3):188723. PubMed ID: 35314212
[TBL] [Abstract][Full Text] [Related]
8. NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway.
Eide PW; Cekaite L; Danielsen SA; Eilertsen IA; Kjenseth A; Fykerud TA; Ågesen TH; Bruun J; Rivedal E; Lothe RA; Leithe E
Cell Signal; 2013 Jan; 25(1):12-8. PubMed ID: 22974840
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization.
Fouladkou F; Landry T; Kawabe H; Neeb A; Lu C; Brose N; Stambolic V; Rotin D
Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8585-90. PubMed ID: 18562292
[TBL] [Abstract][Full Text] [Related]
10. The role of NEDD4 related HECT-type E3 ubiquitin ligases in defective autophagy in cancer cells: molecular mechanisms and therapeutic perspectives.
Zhang R; Shi S
Mol Med; 2023 Mar; 29(1):34. PubMed ID: 36918822
[TBL] [Abstract][Full Text] [Related]
11. Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities
Singh S; Ng J; Nayak D; Sivaraman J
J Biol Chem; 2019 Dec; 294(52):19934-19949. PubMed ID: 31732561
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HECT E3 ligases as potential therapy for COVID-19.
Novelli G; Liu J; Biancolella M; Alonzi T; Novelli A; Patten JJ; Cocciadiferro D; Agolini E; Colona VL; Rizzacasa B; Giannini R; Bigio B; Goletti D; Capobianchi MR; Grelli S; Mann J; McKee TD; Cheng K; Amanat F; Krammer F; Guarracino A; Pepe G; Tomino C; Tandjaoui-Lambiotte Y; Uzunhan Y; Tubiana S; Ghosn J; ; ; ; Notarangelo LD; Su HC; Abel L; Cobat A; Elhanan G; Grzymski JJ; Latini A; Sidhu SS; Jain S; Davey RA; Casanova JL; Wei W; Pandolfi PP
Cell Death Dis; 2021 Mar; 12(4):310. PubMed ID: 33762578
[TBL] [Abstract][Full Text] [Related]
13. HECT-Type E3 Ubiquitin Ligases in Cancer.
Bernassola F; Chillemi G; Melino G
Trends Biochem Sci; 2019 Dec; 44(12):1057-1075. PubMed ID: 31610939
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin Ligase Activities of WWP1 Germline Variants K740N and N745S.
Jiang H; Dempsey DR; Cole PA
Biochemistry; 2021 Feb; 60(5):357-364. PubMed ID: 33470109
[TBL] [Abstract][Full Text] [Related]
15. NEDD4: The founding member of a family of ubiquitin-protein ligases.
Boase NA; Kumar S
Gene; 2015 Feb; 557(2):113-22. PubMed ID: 25527121
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin E3 ligase Nedd4-1 acts as a downstream target of PI3K/PTEN-mTORC1 signaling to promote neurite growth.
Hsia HE; Kumar R; Luca R; Takeda M; Courchet J; Nakashima J; Wu S; Goebbels S; An W; Eickholt BJ; Polleux F; Rotin D; Wu H; Rossner MJ; Bagni C; Rhee JS; Brose N; Kawabe H
Proc Natl Acad Sci U S A; 2014 Sep; 111(36):13205-10. PubMed ID: 25157163
[TBL] [Abstract][Full Text] [Related]
17. The equilibrium of tumor suppression: DUBs as active regulators of PTEN.
Christine A; Park MK; Song SJ; Song MS
Exp Mol Med; 2022 Nov; 54(11):1814-1821. PubMed ID: 36385557
[TBL] [Abstract][Full Text] [Related]
18. Reactivation of PTEN tumor suppressor for cancer treatment through inhibition of a MYC-WWP1 inhibitory pathway.
Lee YR; Chen M; Lee JD; Zhang J; Lin SY; Fu TM; Chen H; Ishikawa T; Chiang SY; Katon J; Zhang Y; Shulga YV; Bester AC; Fung J; Monteleone E; Wan L; Shen C; Hsu CH; Papa A; Clohessy JG; Teruya-Feldstein J; Jain S; Wu H; Matesic L; Chen RH; Wei W; Pandolfi PP
Science; 2019 May; 364(6441):. PubMed ID: 31097636
[TBL] [Abstract][Full Text] [Related]
19. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
[TBL] [Abstract][Full Text] [Related]
20. p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.
Hong SW; Moon JH; Kim JS; Shin JS; Jung KA; Lee WK; Jeong SY; Hwang JJ; Lee SJ; Suh YA; Kim I; Nam KY; Han S; Kim JE; Kim KP; Hong YS; Lee JL; Lee WJ; Choi EK; Lee JS; Jin DH; Kim TW
Cell Death Differ; 2014 Jan; 21(1):146-60. PubMed ID: 24141722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
